rs983041061
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_130837.3(OPA1):c.610+364G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_130837.3 intron
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant optic atrophy, classic formInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- optic atrophyInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathyInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- OPA1-related optic atrophy with or without extraocular featuresInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- Behr syndromeInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type)Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
- autosomal dominant optic atrophy plus syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
The OPA1 gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_130837.2, and corresponds to NM_015560.2:c.557-668G>A in the primary transcript. This sequence change falls in intron 5 of the OPA1 gene. It does not directly change the encoded amino acid sequence of the OPA1 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in this region of OPA1 cause disease. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with autosomal recessive OPA1-related conditions (PMID: 24970096). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 496968). Studies have shown that this variant alters OPA1 gene expression (PMID: 24970096). Studies have shown that this variant results in activation of cryptic splice sites and introduces a premature termination codon (PMID: 24970096). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at